SAFETY AND EFFICACY OF THE FITUSIRAN REVISED ANTITHROMBIN-BASED DOSE REGIMEN IN PEOPLE WITH HAEMOPHILIA A OR B, WITH OR WITHOUT INHIBITORS (ATLAS-OLE) Guy-Young; Kaan-Kavakli; S W-Pipe; Alok-Srivastava; Juliana-Aragao; L A-Menapace; Chuanwu-Zhang; Marja-Puurunen; Marek-Demissie; Gili-Kenet;

SURGICAL EXPERIENCE IN PEOPLE WITH HEMOPHILIA A OR B WITH AND WITHOUT INHIBITORS RECEIVING FITUSIRAN Alok-Srivastava; Pencho-Georgiev; Toshko-Lissitchkov; M V-Ragni; Juliana-Aragao; L A-Menapace; Yuqian-Shen; Marja-Puurunen; Marek-Demissie; S W-Pipe;

ANÁLISE DO PERFIL IMUNOLÓGICO EM PACIENTES COM TROMBOCITOPENIA LIGADA AO X: FREQUÊNCIA DE CÉLULAS TREGS E B DE MEMÓRIA LGR Lima; JO Frade-Guanaes; LH Siqueira; SS Medina; GG Yamaguti-Hayakawa; MMDS Vilela; MC Ozelo;